Theseus Pharmaceuticals Investor Relations - Investor Alerts

Contact

Company
Science
Pipeline
Join Us
Investors & Media

Select Page

Header_Image_Investors

Investor Alerts

Enter the email address that you used to subscribe to this list.

Email

Corporate Communications Contact

Christen Baglaneas
Theseus Pharmaceuticals
857-706-4993
christen.baglaneas@theseusrx.com

Investor Contact

Josh Rappaport
Stern Investor Relations
212-362-1200
josh.rappaport@sternir.com

Company

About Us
Leadership
Contact

Science

Our Approach
Disease Focus
Publications & Posters

Programs

Pipeline
KIT Program
EGFR Program
Discovery Program
Expanded Access Policy

Join Us

Our Culture
Open Roles
Diversity Commitment

Investors

Corporate Profile
News & Events
Stock Information
SEC Filings
Corporate Governance
Resources

© 2023 Theseus Pharmaceuticals. All rights reserved.

Privacy Policy
Terms of Use